List of articles with "Johnson & Johnson"

Eye Health for Women

Eye Health for Women

USA Johnson & Johnson Jacksonville Naomi Watts Eye Exam
Darzalex Approval News

Darzalex Approval News

Japan Johnson & Johnson Tokyo Multiple Myeloma DARZALEX
Aimabi Launch

Aimabi Launch

Japan Johnson & Johnson Tokyo Myasthenia Gravis Aimabi
CAPLYTA®: New Hope for MDD

CAPLYTA®: New Hope for MDD

USA Johnson & Johnson Major Depressive Disorder CAPLYTA Titusville, NJ
Head-to-Head Study

Head-to-Head Study

USA Johnson & Johnson Spring House IMAAVY™ gMG Treatment
Psoriasis Treatment Preferences

Psoriasis Treatment Preferences

USA Johnson & Johnson Spring House Psoriasis Oral Treatments
Promising Icotrokinra Results

Promising Icotrokinra Results

United States Ulcerative Colitis Johnson & Johnson Phoenix Icotrokinra
TREMFYA® Efficacy

TREMFYA® Efficacy

United States TREMFYA® Johnson & Johnson New Brunswick Crohn's Disease
Nipocalimab in Sjögren's

Nipocalimab in Sjögren's

United States Johnson & Johnson Spring House nipocalimab Sjögren's Disease
Icotrokinra Promises Relief

Icotrokinra Promises Relief

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
Jets & Johnson Health

Jets & Johnson Health

United States Johnson & Johnson Florham Park Healthcare Heroes New York Jets
Turby® in Myeloma

Turby® in Myeloma

Japan Johnson & Johnson Tokyo Multiple Myeloma Turby®
Osteoporosis Awareness

Osteoporosis Awareness

Japan Johnson & Johnson Tokyo Osteoporosis Health Literacy
J&J at ECNP 2025

J&J at ECNP 2025

USA Johnson & Johnson Major Depressive Disorder treatment-resistant depression Titusville, NJ
CED Honors Distinguished CEOs

CED Honors Distinguished CEOs

United States New York City Johnson & Johnson Zscaler CED
ACUVUE OASYS MAX Insights

ACUVUE OASYS MAX Insights

USA Johnson & Johnson Jacksonville Contact Lenses ACUVUE OASYS MAX
Icotrokinra Treatment

Icotrokinra Treatment

United States Ulcerative Colitis Johnson & Johnson Spring House Icotrokinra
USOP Partners with J&J

USOP Partners with J&J

United States Johnson & Johnson Alpharetta Orthopaedic Partners Total Joint
J&J Dual Control Initiative

J&J Dual Control Initiative

Japan Johnson & Johnson Tokyo Inflammatory Bowel Disease Dual Control
Reporting Hotline for Compliance

Reporting Hotline for Compliance

USA Johnson & Johnson Scottsdale Innovative Health Medical Devices
Innovative Neurology Solutions

Innovative Neurology Solutions

United States San Diego Johnson & Johnson Neuropsychiatry Psych Congress
INLEXZO™ Approval

INLEXZO™ Approval

United States Johnson & Johnson Bladder Cancer INLEXZO™ RARITAN, N.J.
Johnson & Johnson VARIPURE Results

Johnson & Johnson VARIPURE Results

None Madrid Johnson & Johnson ESC Congress VARIPULSE™ Platform
Impella CP Heart Pump Study

Impella CP Heart Pump Study

United States New York Johnson & Johnson Impella CP cardiogenic shock
Tarbey® Injection Released

Tarbey® Injection Released

Japan Johnson & Johnson Tokyo Multiple Myeloma Tarbey®
Value of Time Campaign

Value of Time Campaign

Japan Johnson & Johnson Tokyo Lung Cancer Value of Time
VIRTUGUIDE™ AI System

VIRTUGUIDE™ AI System

USA Johnson & Johnson West Chester Bunion Surgery VIRTUGUIDE™
TREMFYA® FDA Filing

TREMFYA® FDA Filing

United States TREMFYA® Johnson & Johnson Horsham Psoriatic Arthritis
Biosurgery Market Growth

Biosurgery Market Growth

USA Johnson & Johnson Delray Beach biosurgery market surgical sealants
Alzheimer's Research at AAIC 2025

Alzheimer's Research at AAIC 2025

USA Johnson & Johnson Alzheimer's Disease Titusville AAIC 2025
ICOTROKINRA Moves Forward

ICOTROKINRA Moves Forward

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
TAR-200 FDA Review

TAR-200 FDA Review

USA New Jersey Johnson & Johnson Bladder Cancer TAR-200
CAPLYTA® New Submission

CAPLYTA® New Submission

United States Johnson & Johnson schizophrenia Titusville CAPLYTA
Tarbey® Approved

Tarbey® Approved

Japan Johnson & Johnson Tokyo Multiple Myeloma Tarbey®
ACUVUE OASYS MAX Launch

ACUVUE OASYS MAX Launch

USA Johnson & Johnson Jacksonville Contact Lenses ACUVUE OASYS
Talc Litigation Update

Talc Litigation Update

United States Johnson & Johnson Legal-Bay Trenton Talc Litigation
TECNIS Odyssey IOL Launch

TECNIS Odyssey IOL Launch

United States Johnson & Johnson Jacksonville TECNIS Odyssey IOL
TALVEY and TECVAYLI Results

TALVEY and TECVAYLI Results

United States Johnson & Johnson New Brunswick TALVEY TECVAYLI
New CAR T-Cell Therapy

New CAR T-Cell Therapy

USA Milan Johnson & Johnson CAR T-Cell JNJ-4496
Bleximenib Phase 1b Results

Bleximenib Phase 1b Results

United States Johnson & Johnson New Brunswick AML Bleximenib
J&J New Myeloma Treatment

J&J New Myeloma Treatment

USA Chicago Johnson & Johnson Multiple Myeloma JNJ-79635322
CARVYKTI® Long-Term Remission

CARVYKTI® Long-Term Remission

United States Chicago Johnson & Johnson Multiple Myeloma CARVYKTI
DARZALEX FASPRO® Success

DARZALEX FASPRO® Success

USA Chicago Johnson & Johnson Multiple Myeloma DARZALEX FASPRO
Hope for Prostate Cancer

Hope for Prostate Cancer

USA Chicago Johnson & Johnson Prostate Cancer AKEEGA
KINCISE™ 2 Launch

KINCISE™ 2 Launch

United States Johnson & Johnson Palm Beach Gardens KINCISE Surgical System
Promising Cancer Treatment

Promising Cancer Treatment

United States Chicago Johnson & Johnson Prostate Cancer pasritamig
Revolutionizing Intracardiac Imaging

Revolutionizing Intracardiac Imaging

United States Johnson & Johnson Irvine SOUNDSTAR CRYSTAL CARTO 3 System
Tremfya® Released

Tremfya® Released

Japan Ulcerative Colitis TREMFYA® Johnson & Johnson Tokyo
FDA Backs DARZALEX FASPRO®

FDA Backs DARZALEX FASPRO®

United States Johnson & Johnson Multiple Myeloma Raritan, NJ DARZALEX FASPRO®
Tremfya® Long-Term Results

Tremfya® Long-Term Results

USA San Diego Ulcerative Colitis Johnson & Johnson TREMFYA

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.